Clinical Trial

Herpes Virus Infections in Kidney Transplant Patients

Study acronym: HINT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Kidney transplant recipients are at increased risk of infections, including Varicella-zoster virus (VZV) infections. Vaccination against VZV is routinely offered to all kidney transplant recipients and candidates in Denmark. In this exploratory observational study, the VZV specific immune response in kidney transplant candidates and recipients will be characterized at different time points in relation to transplantation, vaccination and infections. More knowledge on the immune reaction to transplantation, VZV vaccination and VZV infections may provide improved strategies for prevention and treatment of VZV infections in kidney transplant candidates and recipients.
Protocol Amendment History 1 change
minor Completion pushed: 2026-02-01 -> 2030-12-31 2026-08-13
Trial Details
NCT Number NCT05604911
Lead Sponsor Susanne Dam Nielsen, MD, DMSc
Collaborators: Technical University of Denmark, Aarhus University Hospital, Odense University Hospital
Conditions Kidney Transplant; Complications, Varicella Zoster Virus Infection, Vaccine-Preventable Diseases
Enrollment 280 participants
Start Date 2023-01-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12